pediatric endocrinology Archives
Trial participant steps up to help advance diabetes research
Sep. 1, 2022—Vanderbilt is one of 16 North American sites conducting the Tolerance Using Plasmid in People with Type 1 Diabetes (TOPPLE) study, a phase 1 investigation that tests the safety and dosing of a new plasmid therapy.
New insights into hypothalamic obesity
Feb. 10, 2022—A common Type 2 diabetes treatment being tested for hypothalamic obesity had unexpected results on weight loss and total energy expenditure, Vanderbilt researchers report.
‘Pre-conditioning’ restores immune tolerance
Sep. 16, 2021—A treatment targeting T-cell metabolism could reinvigorate immune tolerance mechanisms to combat autoimmune disease and transplant rejection, Vanderbilt researchers discovered.
New treatment for a rare obesity
Nov. 3, 2020—Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity.
Simmons strives to make a difference in children’s lives
Aug. 13, 2015—Jill Simmons, M.D., encounters medical mysteries that have the makings of a science fiction film or novel.
VU tracking drug’s ability to prevent type 1 diabetes
Sep. 12, 2013—Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.
New protocol takes the sting out of Children’s Hospital outpatient procedures
Jun. 13, 2013—A patient comfort protocol is rendering minor procedures less painful and upsetting for younger outpatients of the Monroe Carell Jr. Children’s Hospital at Vanderbilt.
Therapy helps regenerate child’s undeveloped bones
Apr. 11, 2013—Janelly Martinez-Amador was born with thin, fragile bones, and by 3, she had no visible bones on X-rays. Initially, doctors weren’t sure she would survive her first birthday.
Little Leaguer is a diabetes pro
Sep. 27, 2012—Middle Tennessee’s latest celebrities are the 11-and-12-year-old Little League U.S. World Series Champions from Goodlettesville. But one young player already had quite a fan base built up at a Vanderbilt pediatric diabetes clinic, where he has been a patient most of his life. Luke Brown and his family are also long-time participants in TrialNet Type...
Diabetes can’t hold back Little League champion
Aug. 30, 2012—When Luke Brown was 5, he slid into second base as a little black box flew out of the back pocket of his baseball pants. The object was an insulin pump, his lifeline, a device charged with keeping his blood sugar in check. But he wasn’t prepared to stop at second, and snatched it off...
‘U.S. News’ ranks Monroe Carell Jr. Children’s Hospital at Vanderbilt among nation’s best
May. 17, 2011—Once again the Monroe Carell Children's Hospital at Vanderbilt was recognized by the "U.S. News and World Report' children's hospital rankings.
